RICCI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 19.823
AS - Asia 3.475
EU - Europa 2.325
SA - Sud America 501
AF - Africa 396
OC - Oceania 301
Continente sconosciuto - Info sul continente non disponibili 250
Totale 27.071
Nazione #
US - Stati Uniti d'America 19.590
SG - Singapore 1.099
CN - Cina 625
BR - Brasile 364
RU - Federazione Russa 356
IT - Italia 354
DE - Germania 328
IN - India 313
AU - Australia 293
GB - Regno Unito 264
HK - Hong Kong 244
ID - Indonesia 238
UA - Ucraina 218
IE - Irlanda 213
VN - Vietnam 209
FR - Francia 166
BD - Bangladesh 96
SE - Svezia 92
CA - Canada 86
MX - Messico 86
JP - Giappone 81
PL - Polonia 80
KR - Corea 78
FI - Finlandia 67
GH - Ghana 63
PK - Pakistan 63
NG - Nigeria 61
PH - Filippine 58
ZA - Sudafrica 58
TR - Turchia 56
KE - Kenya 52
MY - Malesia 49
TH - Thailandia 46
EG - Egitto 41
NL - Olanda 41
TW - Taiwan 36
AR - Argentina 34
ET - Etiopia 34
IQ - Iraq 34
EC - Ecuador 27
SA - Arabia Saudita 21
ES - Italia 19
IR - Iran 19
NP - Nepal 19
BE - Belgio 18
CL - Cile 18
CO - Colombia 16
LT - Lituania 16
IL - Israele 15
AT - Austria 13
MU - Mauritius 13
PE - Perù 13
JM - Giamaica 12
UG - Uganda 12
VE - Venezuela 12
KG - Kirghizistan 11
ZM - Zambia 11
CR - Costa Rica 10
MA - Marocco 10
PT - Portogallo 10
RO - Romania 10
MG - Madagascar 9
NO - Norvegia 9
EE - Estonia 8
GT - Guatemala 8
AE - Emirati Arabi Uniti 7
KH - Cambogia 7
PY - Paraguay 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
MW - Malawi 6
NZ - Nuova Zelanda 6
AZ - Azerbaigian 5
BO - Bolivia 5
CH - Svizzera 5
CM - Camerun 5
GR - Grecia 5
JO - Giordania 5
LV - Lettonia 5
NI - Nicaragua 5
TZ - Tanzania 5
AL - Albania 4
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
KZ - Kazakistan 4
MM - Myanmar 4
QA - Qatar 4
TN - Tunisia 4
BG - Bulgaria 3
BH - Bahrain 3
GE - Georgia 3
KW - Kuwait 3
LB - Libano 3
MR - Mauritania 3
PA - Panama 3
PR - Porto Rico 3
BT - Bhutan 2
BY - Bielorussia 2
Totale 26.782
Città #
Woodbridge 4.670
Wilmington 4.383
Houston 4.366
Singapore 654
Ashburn 539
Fairfield 506
Ann Arbor 393
Chandler 377
San Jose 366
Seattle 247
Beijing 201
Hong Kong 199
Dublin 198
Cambridge 197
Jacksonville 190
Medford 161
New York 156
Council Bluffs 149
Dearborn 140
Los Angeles 117
Santa Clara 110
Perth 103
The Dalles 95
Rome 94
Ho Chi Minh City 75
Boardman 74
Lawrence 73
Melbourne 70
Moscow 70
Tokyo 66
Jakarta 63
Denver 59
Zhengzhou 53
Buffalo 49
Kraków 49
Lauterbourg 48
Hanoi 47
Sydney 46
Chennai 44
Munich 43
Nairobi 43
São Paulo 43
Accra 42
Dallas 42
Chicago 41
Bangkok 40
Milan 36
San Diego 34
Kuala Lumpur 27
Montreal 26
Mülheim 26
London 25
Shanghai 25
Mexico City 23
Orem 23
Phoenix 23
Malang 22
Waurn Ponds 22
Atlanta 21
Bengaluru 21
Menlo Park 21
San Francisco 21
Manila 20
Manchester 19
Cairo 18
Guangzhou 18
Helsinki 18
Lagos 18
Nuremberg 18
Toronto 18
Washington 18
Brussels 17
Hyderabad 17
Istanbul 17
Johannesburg 17
Mumbai 17
Riyadh 17
Warsaw 17
Abuja 16
Baghdad 16
North Bergen 16
Bodorgan 15
Rio de Janeiro 15
Shenzhen 15
Taipei 15
Frankfurt am Main 14
Kansas City 14
Karachi 14
Kathmandu 14
Lahore 14
Nanjing 14
Pune 14
Birmingham 13
Brasília 13
Denpasar 13
Dhaka 13
Guayaquil 13
Kolkata 13
Surabaya 13
Aksum 12
Totale 20.780
Nome #
A literature review of hypertensive retinopathy: systemic correlations and new technologies 2.625
CLU "in and out": looking for a link. 597
Validity and limitations of the Nidek NT-4000 non-contact tonometer: a clinical study 535
Review of nutrient actions on age-related macular degeneration 525
Visual disability and quality of life in glaucoma patients 512
Electro-oculography in pigment dispersion syndrome 510
Age-related macular degeneration: insights into inflammatory genes 508
Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry. 508
Automatic Segmentation of Posterior Pole Retinal Layers In Patients with Early Stage Glaucoma Using Spectral Domain Optical Coherence Tomography 507
Clusterin in stool: a new biomarker for colon cancer screening? 493
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 484
Age-specific changes in the prevalence and management of optically correctable visual impairment between 1988 and 2000: the Ponza Eye Study 483
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 479
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 475
Age-specific changes in the prevalence of best-corrected visual impairment in an italian population 469
Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy 466
Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization 466
The 12-year Incidence of Glaucoma and Glaucoma-related Visual Field Loss in Italy: The Ponza Eye Study 458
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks 457
Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy 454
Prevalence of blindness and low vision in an Italian population: A comparison with other European studies 452
Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population 451
Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab 451
Evaluation of pupillary response to light in patients with glaucoma: a study using computerized pupillometry 450
Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinpathy (AZOOR) with adalimumab (Humira™). 449
Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration 444
CLU "in and out": looking for a link 442
Prevalence and risk factors of vision impairment among children of employees of Telecom, Italy. 440
Low contrast visual acuity in pseudophakic patients implanted with an anterior surface modified prolate intraocular lens 438
Clusterin in stool: a new biomarker for colon cancer screening? 436
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 432
Incidence of visual loss in the Ponza Eye Study, Italy 431
Prevalence and incidence of age-related cataract in a population sample from Priverno, Italy. Ophthalmic Epidemiol. 1999 Jun;6(2):95-103. 425
ICGA Guided Low-fluence Photodynamic Therapy Combined With PRN Ranibizumab For Active Polypoidal Choroidal Vasculopathy 422
Nationwide incidence of endophthalmitis among the general population and the subjects at risk of endophthalmitis in Italy 421
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 421
Persistent epithelial defect after penetrating keratoplasty caused by adenoviral infectious keratitis 418
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 407
Evaluation of fixation stability using different targets with the MP1 microperimeter 404
Monolateral Corectopia: considerations about associated myopia. A case report. 390
Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration 381
Indocyanine green angiography and optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration 352
L’epidemiologia del glaucoma 339
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization 328
Towards the application of precision medicine in age-related macular degeneration 328
Moorfields Regression Analysis (MRA) and Glaucoma Probability Score (GPS) Agreement in Daily Clinical Practice 327
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: The RETAIN study 311
The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A. 290
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 278
Using real-world data to estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness 259
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial 253
Ultrasound-Guided Vacuum-Assisted Biopsy in Small Breast: A Cost-Saving Solution 230
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 223
Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa 211
Platelet-rich plasma as treatment for persistent ocular epithelial defects 177
Thickness mapping of individual retinal layers and sectors by Spectralis Spectral Domain-optical Coherence Tomography in Autosomal Dominant Optic Atrophy 120
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials 116
Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data 112
A cluster of presumed, noninfectious endophthalmitis after intravitreal injection of bevacizumab: long-term follow-up 107
Antimicrobial activity on contact lenses contaminated with planktonic and sessile forms of bacteria: An experimental approach 105
Optical coherence tomography angiography in the multimodal assessment of the retinal posterior pole in autosomal dominant optic atrophy 103
Definition of indicators of appropriateness in the management of neovascular age-related macular degeneration: An expert opinion 101
Aflibercept in persistent neovascular AMD: Comparison of different treatment strategies in switching therapy 99
Ranibizumab for visual impairment due to diabetic macular edema: Real-world evidence in the Italian population (pride study) 96
Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets 96
Genetic determinants highlight the existence of shared etiopathogenetic mechanisms characterizing age-related macular degeneration and neurodegenerative disorders 91
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial 83
Effectiveness of anti-vascular endothelial growth factors in neovascular age-related macular degeneration and variables associated with visual acuity outcomes: Results from the EAGLE study 83
An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification 83
Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration 78
Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study 78
Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach 78
Neovascular age-related macular degeneration: Therapeutic management and new-upcoming approaches 78
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases 77
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 77
Paper card-like electrochemical platform as a smart point-of-care device for reagent-free glucose measurement in tears 69
Longitudinal Structural and Functional Evaluation of Dark-without-Pressure Fundus Lesions in Patients with Autoimmune Diseases 69
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 62
Correction: Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries (Eye, (2023), 37, 16, (3351-3359), 10.1038/s41433-023-02540-w) 45
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 43
Totale 27.071
Categoria #
all - tutte 67.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.025


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022601 0 0 0 26 12 55 120 30 36 53 83 186
2022/2023962 105 81 24 100 104 211 75 93 84 2 60 23
2023/20241.066 91 45 70 71 99 172 88 60 70 72 49 179
2024/20252.751 132 428 270 145 150 191 247 204 276 205 291 212
2025/20263.900 395 159 458 413 290 183 353 500 485 285 225 154
2026/20271.176 195 182 592 207 0 0 0 0 0 0 0 0
Totale 27.071